🟢 Femasys is trading 7.09% up in after-hours trading after Minnesota Women’s Care adopted FemVue, FemaSeed Complete

Femasys is trading 7.09% up now at $2.72 in after-hours trading after Minnesota Women’s Care announced adoption of FemVue and FemaSeed Complete across all four OB/GYN locations.

• The September 15, 2026 announcement expands Femasys’ commercial fertility portfolio footprint.
• It supports broader in-office diagnostic and first-line treatment access; the company’s release does not report additional after-hours trading details.